Angiopoietin-2 predicts morbidity in adults with Fontan physiology

Aditya S. Shirali; Gentian Lluri; Pierre J. Guihard; Miles B. Conrad; Helen Kim; Ludmila Pawlikowska; Kristina I. Boström; M. Luisa Iruela-Arispe; Jamil A. Aboulhosn

doi:10.1038/s41598-019-54776-w

Angiopoietin-2 predicts morbidity in adults with Fontan physiology

Aditya S. Shirali, Gentian Lluri^*, Pierre J. Guihard, Miles B. Conrad, Helen Kim, Ludmila Pawlikowska, Kristina I. Boström, M. Luisa Iruela-Arispe, Jamil A. Aboulhosn

^*Corresponding author for this work

Cell & Developmental Biology

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Morbidity in patients with single-ventricle Fontan circulation is common and includes arrhythmias, edema, and pulmonary arteriovenous malformations (PAVM) among others. We sought to identify biomarkers that may predict such complications. Twenty-five patients with Fontan physiology and 12 control patients with atrial septal defects (ASD) that underwent cardiac catheterization were included. Plasma was collected from the hepatic vein and superior vena cava and underwent protein profiling for a panel of 20 analytes involved in angiogenesis and endothelial dysfunction. Ten (40%) of Fontan patients had evidence of PAVM, eighteen (72%) had a history of arrhythmia, and five (20%) were actively in arrhythmia or had a recent arrhythmia. Angiopoietin-2 (Ang-2) was higher in Fontan patients (8,875.4 ± 3,336.9 pg/mL) versus the ASD group (1,663.6 ± 587.3 pg/mL, p < 0.0001). Ang-2 was higher in Fontan patients with active or recent arrhythmia (11,396.0 ± 3,457.7 vs 8,118.2 ± 2,795.1 pg/mL, p < 0.05). A threshold of 8,500 pg/mL gives Ang-2 a negative predictive value of 100% and positive predictive value of 42% in diagnosing recent arrhythmia. Ang-2 is elevated among adults with Fontan physiology. Ang-2 level is associated with active or recent arrhythmia, but was not found to be associated with PAVM.

Original language	English (US)
Article number	18328
Journal	Scientific reports
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41598-019-54776-w
State	Published - Dec 1 2019

Funding

We would like to thank Rachel Bolanos, Gregory Petersen, Soraya Sadeghi, and Dr. Jana Tarabay for their efforts in enrolling patients in this study, and the study coordinators at UCSF HHT Center of Excellence and UCSF Center for Cerebrovascular Research, Melissa Dickey and Diana Guo, for providing plasma samples from HHT patients with PAVMs. This work was supported by the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Clinical Fellowship Training Program (AS), by the Streisand Endowed Chair (JAA) in Clinical Cardiology at UCLA, and NIH grants HL81397 and HL112839 (KIB) at UCLA, and by R01 NS034949 (HK) and U54 NS065705 (Michael Lawton) at UCSF.

ASJC Scopus subject areas

General

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41598-019-54776-w

Cite this

@article{e14e6a314e3c4a49bab9881d233b4703,

title = "Angiopoietin-2 predicts morbidity in adults with Fontan physiology",

abstract = "Morbidity in patients with single-ventricle Fontan circulation is common and includes arrhythmias, edema, and pulmonary arteriovenous malformations (PAVM) among others. We sought to identify biomarkers that may predict such complications. Twenty-five patients with Fontan physiology and 12 control patients with atrial septal defects (ASD) that underwent cardiac catheterization were included. Plasma was collected from the hepatic vein and superior vena cava and underwent protein profiling for a panel of 20 analytes involved in angiogenesis and endothelial dysfunction. Ten (40%) of Fontan patients had evidence of PAVM, eighteen (72%) had a history of arrhythmia, and five (20%) were actively in arrhythmia or had a recent arrhythmia. Angiopoietin-2 (Ang-2) was higher in Fontan patients (8,875.4 ± 3,336.9 pg/mL) versus the ASD group (1,663.6 ± 587.3 pg/mL, p < 0.0001). Ang-2 was higher in Fontan patients with active or recent arrhythmia (11,396.0 ± 3,457.7 vs 8,118.2 ± 2,795.1 pg/mL, p < 0.05). A threshold of 8,500 pg/mL gives Ang-2 a negative predictive value of 100% and positive predictive value of 42% in diagnosing recent arrhythmia. Ang-2 is elevated among adults with Fontan physiology. Ang-2 level is associated with active or recent arrhythmia, but was not found to be associated with PAVM.",

author = "Shirali, {Aditya S.} and Gentian Lluri and Guihard, {Pierre J.} and Conrad, {Miles B.} and Helen Kim and Ludmila Pawlikowska and Bostr{\"o}m, {Kristina I.} and Iruela-Arispe, {M. Luisa} and Aboulhosn, {Jamil A.}",

note = "Publisher Copyright: {\textcopyright} 2019, The Author(s).",

year = "2019",

month = dec,

day = "1",

doi = "10.1038/s41598-019-54776-w",

language = "English (US)",

volume = "9",

journal = "Scientific reports",

issn = "2045-2322",

publisher = "Nature Research",

number = "1",

}

TY - JOUR

T1 - Angiopoietin-2 predicts morbidity in adults with Fontan physiology

AU - Shirali, Aditya S.

AU - Lluri, Gentian

AU - Guihard, Pierre J.

AU - Conrad, Miles B.

AU - Kim, Helen

AU - Pawlikowska, Ludmila

AU - Boström, Kristina I.

AU - Iruela-Arispe, M. Luisa

AU - Aboulhosn, Jamil A.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Morbidity in patients with single-ventricle Fontan circulation is common and includes arrhythmias, edema, and pulmonary arteriovenous malformations (PAVM) among others. We sought to identify biomarkers that may predict such complications. Twenty-five patients with Fontan physiology and 12 control patients with atrial septal defects (ASD) that underwent cardiac catheterization were included. Plasma was collected from the hepatic vein and superior vena cava and underwent protein profiling for a panel of 20 analytes involved in angiogenesis and endothelial dysfunction. Ten (40%) of Fontan patients had evidence of PAVM, eighteen (72%) had a history of arrhythmia, and five (20%) were actively in arrhythmia or had a recent arrhythmia. Angiopoietin-2 (Ang-2) was higher in Fontan patients (8,875.4 ± 3,336.9 pg/mL) versus the ASD group (1,663.6 ± 587.3 pg/mL, p < 0.0001). Ang-2 was higher in Fontan patients with active or recent arrhythmia (11,396.0 ± 3,457.7 vs 8,118.2 ± 2,795.1 pg/mL, p < 0.05). A threshold of 8,500 pg/mL gives Ang-2 a negative predictive value of 100% and positive predictive value of 42% in diagnosing recent arrhythmia. Ang-2 is elevated among adults with Fontan physiology. Ang-2 level is associated with active or recent arrhythmia, but was not found to be associated with PAVM.

AB - Morbidity in patients with single-ventricle Fontan circulation is common and includes arrhythmias, edema, and pulmonary arteriovenous malformations (PAVM) among others. We sought to identify biomarkers that may predict such complications. Twenty-five patients with Fontan physiology and 12 control patients with atrial septal defects (ASD) that underwent cardiac catheterization were included. Plasma was collected from the hepatic vein and superior vena cava and underwent protein profiling for a panel of 20 analytes involved in angiogenesis and endothelial dysfunction. Ten (40%) of Fontan patients had evidence of PAVM, eighteen (72%) had a history of arrhythmia, and five (20%) were actively in arrhythmia or had a recent arrhythmia. Angiopoietin-2 (Ang-2) was higher in Fontan patients (8,875.4 ± 3,336.9 pg/mL) versus the ASD group (1,663.6 ± 587.3 pg/mL, p < 0.0001). Ang-2 was higher in Fontan patients with active or recent arrhythmia (11,396.0 ± 3,457.7 vs 8,118.2 ± 2,795.1 pg/mL, p < 0.05). A threshold of 8,500 pg/mL gives Ang-2 a negative predictive value of 100% and positive predictive value of 42% in diagnosing recent arrhythmia. Ang-2 is elevated among adults with Fontan physiology. Ang-2 level is associated with active or recent arrhythmia, but was not found to be associated with PAVM.

UR - http://www.scopus.com/inward/record.url?scp=85075994190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075994190&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-54776-w

DO - 10.1038/s41598-019-54776-w

M3 - Article

C2 - 31797976

AN - SCOPUS:85075994190

SN - 2045-2322

VL - 9

JO - Scientific reports

JF - Scientific reports

IS - 1

M1 - 18328

ER -

Angiopoietin-2 predicts morbidity in adults with Fontan physiology

Abstract

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this